Li L, Zhao J
Sci Rep. 2024; 14(1):23230.
PMID: 39369036
PMC: 11455948.
DOI: 10.1038/s41598-024-73724-x.
Wang B, Xiong Y, Deng X, Wang Y, Gong S, Yang S
Front Immunol. 2024; 15:1423784.
PMID: 39238645
PMC: 11374600.
DOI: 10.3389/fimmu.2024.1423784.
Li X, Gao L, Li X, Xia J, Pan Y, Bai C
Diabetes Metab Syndr Obes. 2024; 17:1289-1299.
PMID: 38505538
PMC: 10949337.
DOI: 10.2147/DMSO.S450695.
Asghari K, Niknam Z, Mohammadpour-Asl S, Chodari L
Mol Biol Rep. 2024; 51(1):273.
PMID: 38302794
DOI: 10.1007/s11033-024-09242-w.
Curran C, Kopp J
J Transl Med. 2023; 21(1):706.
PMID: 37814337
PMC: 10563221.
DOI: 10.1186/s12967-023-04584-8.
The Mechanism of Plantaginis Semen in the Treatment of Diabetic Nephropathy based on Network Pharmacology and Molecular Docking Technology.
He L, Shen K, He L, Chen Y, Tang Z
Endocr Metab Immune Disord Drug Targets. 2023; 24(3):363-379.
PMID: 37718520
DOI: 10.2174/1871530323666230915100355.
The role of TET2-mediated ROBO4 hypomethylation in the development of diabetic retinopathy.
Zhao L, Xu H, Liu X, Cheng Y, Xie J
J Transl Med. 2023; 21(1):455.
PMID: 37430272
PMC: 10332081.
DOI: 10.1186/s12967-023-04310-4.
HOGA1 variants in Chinese patients with primary hyperoxaluria type 3: genetic features and genotype-phenotype relationships.
Ge Y, Liu Y, Zhan R, Zhao Z, Li J, Wang W
World J Urol. 2023; 41(8):2141-2148.
PMID: 37318624
DOI: 10.1007/s00345-023-04461-5.
Evaluating the distinct pleiotropic effects of omega-3 fatty acids on type 2 diabetes mellitus: a mendelian randomization study.
Hu C, Zhou Y, Wu X, Jia X, Zhu Y, Zheng R
J Transl Med. 2023; 21(1):370.
PMID: 37286992
PMC: 10249205.
DOI: 10.1186/s12967-023-04202-7.
ADAM metallopeptidase domain 10 knockdown enables podocytes to resist high glucose stimulation by inhibiting pyroptosis via MAPK pathway.
Sui C, Zhou D
Exp Ther Med. 2023; 25(6):260.
PMID: 37153901
PMC: 10155254.
DOI: 10.3892/etm.2023.11959.
Identification of transcription factors related to diabetic tubulointerstitial injury.
Liu J, Duan G, Yang W, Zhang S, Liu F, Peng Y
J Transl Med. 2023; 21(1):228.
PMID: 36978091
PMC: 10053902.
DOI: 10.1186/s12967-023-04069-8.
Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders.
Kitamura H
Int J Mol Sci. 2023; 24(4).
PMID: 36834633
PMC: 9966627.
DOI: 10.3390/ijms24043219.
Argonaute 2 Restores Erectile Function by Enhancing Angiogenesis and Reducing Reactive Oxygen Species Production in Streptozotocin (STZ)-Induced Type-1 Diabetic Mice.
Liu F, Yin G, Ock J, Fridayana F, Niloofar L, Huang Y
Int J Mol Sci. 2023; 24(3).
PMID: 36769259
PMC: 9918048.
DOI: 10.3390/ijms24032935.
Incorporating knowledge of disease-defining hub genes and regulatory network into a machine learning-based model for predicting treatment response in lupus nephritis after the first renal flare.
Lee D, Tsai P, Chen C, Dai Y
J Transl Med. 2023; 21(1):76.
PMID: 36737814
PMC: 9898995.
DOI: 10.1186/s12967-023-03931-z.
Uncovering the gene regulatory network of type 2 diabetes through multi-omic data integration.
Liu J, Liu S, Yu Z, Qiu X, Jiang R, Li W
J Transl Med. 2022; 20(1):604.
PMID: 36527108
PMC: 9756634.
DOI: 10.1186/s12967-022-03826-5.
Reconstruction of the gastric cancer microenvironment after neoadjuvant chemotherapy by longitudinal single-cell sequencing.
Chen Y, Yin J, Zhao L, Zhou G, Dong S, Zhang Y
J Transl Med. 2022; 20(1):563.
PMID: 36474268
PMC: 9724296.
DOI: 10.1186/s12967-022-03792-y.
San-Huang-Yi-Shen Capsule Ameliorates Diabetic Kidney Disease through Inducing PINK1/Parkin-Mediated Mitophagy and Inhibiting the Activation of NLRP3 Signaling Pathway.
Li H, Wang Y, Su X, Wang Q, Zhang S, Sun W
J Diabetes Res. 2022; 2022:2640209.
PMID: 36425593
PMC: 9681560.
DOI: 10.1155/2022/2640209.
Integrated bioinformatics analysis reveals novel key biomarkers in diabetic nephropathy.
Joshi H, Vastrad B, Joshi N, Vastrad C
SAGE Open Med. 2022; 10:20503121221137005.
PMID: 36385790
PMC: 9661593.
DOI: 10.1177/20503121221137005.
Ophthalmic artery changes in type 2 diabetes with and without acute coronary syndrome.
Wu L, Wang J, Wang Y
J Transl Med. 2022; 20(1):512.
PMID: 36335387
PMC: 9636615.
DOI: 10.1186/s12967-022-03712-0.
SGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney disease.
Lu Y, Zhang Z, Wu H, Fang L, Hu B, Tang C
J Transl Med. 2022; 20(1):420.
PMID: 36104729
PMC: 9476562.
DOI: 10.1186/s12967-022-03629-8.